Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 mars 2018 09h06 HE | Source: ProPhase Labs, Inc.

ProPhase Labs Reports Financial Results for the Year Ended December 31, 2017

DOYLESTOWN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH), (www.ProPhaseLabs.com) today reported its net sales from continuing operations were $9.9 million for the year...
16 mars 2018 10h23 HE | Source: ProPhase Labs, Inc.

ProPhase Labs to Release Fiscal 2017 Results on Wednesday, March 21st

DOYLESTOWN, Pa., March 16, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs (NASDAQ:PRPH) announced today that financial results for the year ended December 31, 2017, will be released before the market opens...
20 févr. 2018 19h15 HE | Source: ProPhase Labs, Inc.

ProPhase Labs, Inc. Announces New Compensatory Arrangement With Chief Executive Officer and Termination of Stockholder Rights Plan

DOYLESTOWN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a vertically integrated and diversified branding, marketing and technology company with...
21 déc. 2017 16h00 HE | Source: ProPhase Labs, Inc.

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

DOYLESTOWN, Pa., Dec. 21, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (“ProPhase”), announced today the...
19 déc. 2017 16h30 HE | Source: ProPhase Labs, Inc.

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

DOYLESTOWN, Pa., Dec. 19, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (“ProPhase”), announced today the...
20 nov. 2017 20h30 HE | Source: ProPhase Labs, Inc.

ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 1.7 Million Shares of Its Common Stock at Price of $2.30 Per Share

DOYLESTOWN, Pa., Nov. 20, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the “Company” or “ProPhase”), today...
13 nov. 2017 08h30 HE | Source: ProPhase Labs, Inc.

ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017

DOYLESTOWN, Pennsylvania, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com) today reported its financial results for the three months and nine months ended...
10 nov. 2017 08h00 HE | Source: ProPhase Labs, Inc.

Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock

DOYLESTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the “Company” or “ProPhase”), today...
29 sept. 2017 08h30 HE | Source: ProPhase Labs, Inc.

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

DOYLESTOWN, Pa., Sept. 29, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (“ProPhase”), announced today the...
26 sept. 2017 16h05 HE | Source: ProPhase Labs, Inc.

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

DOYLESTOWN, Pa., Sept. 26, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (“ProPhase”), announced today the...

Page précédente